About Kimberly Muller
Form D filings for OncoVerity in 2024 list Kimberly Muller as director.
Kimberly Muller first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Kimberly Muller in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kimberly Muller works with at each company, as listed on that company's latest Form D.
OncoVerity, Inc. · Form D, Dec 10, 2024
MC
Massimiliano Colao
Chief Executive Officer and director
AL
Arjen Lemmen
Director
PV
Petra Van Vlierberghe
Director
SH
Steven Hess
Director
CS
Clayton Smith
Chief Medical Officer